Infective endocarditis resident survival guide: Difference between revisions
Line 5: | Line 5: | ||
==Definition== | ==Definition== | ||
[[Infection]] of the [[endothelium]] of the heart including but not limited to the valves. It can be either [[acute]] or [[subacute]]. Acute bacterial endocarditis is defined as [[Infection]] of normal [[heart valves]] with a virulent organism like [[S. aureus]], Group A or other [[beta-hemolytic streptococci]], [[Streptococcus pneumoniae]]. Subacute bacterial endocarditis is an indolent infection of abnormal valves with less virulent organism like [[Streptococcus viridans]]. | [[Infection]] of the [[endothelium]] of the heart including but not limited to the valves. It can be either [[acute]] or [[subacute]]. Acute bacterial endocarditis is defined as [[Infection]] of normal [[heart valves]] with a virulent organism like [[S. aureus]], Group A or other [[beta-hemolytic streptococci]], [[Streptococcus pneumoniae]]. Subacute bacterial endocarditis is an indolent infection of abnormal valves with less virulent organism like [[Streptococcus viridans]]. | ||
{|class="wikitable" | {|class="wikitable" | ||
Line 11: | Line 10: | ||
|- | |- | ||
| '''Pathological Criteria'''|| | | '''Pathological Criteria'''|| | ||
: Microorganisms demonstrated by culture or histological examination of a vegetation | :Microorganisms demonstrated by culture or histological examination of a vegetation | ||
: Pathological lesions; vegetation or intracardiac abscess confirmed by histological examination showing active endocarditis | :Pathological lesions; vegetation or intracardiac abscess confirmed by histological examination showing active endocarditis | ||
|- | |- | ||
| '''Clinical Criteria''' || | | '''Clinical Criteria''' || | ||
: 2 major criteria; or | :2 major criteria; or | ||
: 1 major criterion and 3 minor criteria; or | :1 major criterion and 3 minor criteria; or | ||
: 5 minor criteria | :5 minor criteria | ||
|- | |- | ||
| '''Possible IE''' || | | '''Possible IE''' || | ||
: 1 major criterion and 1 minor criterion; or | :1 major criterion and 1 minor criterion; or | ||
: 3 minor criteria | :3 minor criteria | ||
|- | |- | ||
| '''Rejected''' || | | '''Rejected''' || | ||
: Firm alternative diagnosis explaining evidence of IE; or | :Firm alternative diagnosis explaining evidence of IE; or | ||
: Resolution of IE syndrome with antibiotic therapy for 4 days; or | :Resolution of IE syndrome with antibiotic therapy for 4 days; or | ||
: No pathological evidence of IE at surgery or autopsy, with antibiotic therapy for 4 days; or | :No pathological evidence of IE at surgery or autopsy, with antibiotic therapy for 4 days; or | ||
: Does not meet criteria for possible IE as above | :Does not meet criteria for possible IE as above | ||
|- | |- | ||
|} | |} |
Revision as of 15:17, 28 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farman Khan, MD, MRCP [2]
Definition
Infection of the endothelium of the heart including but not limited to the valves. It can be either acute or subacute. Acute bacterial endocarditis is defined as Infection of normal heart valves with a virulent organism like S. aureus, Group A or other beta-hemolytic streptococci, Streptococcus pneumoniae. Subacute bacterial endocarditis is an indolent infection of abnormal valves with less virulent organism like Streptococcus viridans.
Criteria | Definite Infective Endocarditis According to Modified Duke Criteria |
---|---|
Pathological Criteria |
|
Clinical Criteria |
|
Possible IE |
|
Rejected |
|
Definite Infective Endocarditis According to Modified Duke Criteria | |||||||||||||||||||||||||||||
Pathological Criteria
Clinical Criteria
Possible IE
Rejected
| |||||||||||||||||||||||||||||
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Endocarditis can be a life-threatening condition if it is left untreated, and it must be treated as such irrespective of the causes.
Common Causes
Management
Diagnostic Criteria
Shown below is an algorithm depicting the diagnostic criteria of infective endocarditis based on the 2005 American Heart Association (AHA) technical review and medical position statement regarding guidelines on infective endocarditis.[1]
Duke Criteria | |||||||||||||||||||||||||||||||||||||||||||||||||||
The Duke Clinical Criteria for Infective Endocarditis requires either:
❑ Two major criteria, or ❑ One major and three minor criteria, or ❑ Five minor criteria | |||||||||||||||||||||||||||||||||||||||||||||||||||
Major Criteria | Minor criteria | ||||||||||||||||||||||||||||||||||||||||||||||||||
Positive Blood Culture for Infective Endocarditis
Echocardiographic evidence of endocardial involvement
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic approach
Shown below is an algorithm summarizing the approach to infective endocarditis.
A1 Box 1 in Row 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B1 Box 1 in Row 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C1 Box 1 in Row 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Box 4 in row 4 | Box 5 in row 4 | Box 6 in row 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Box 7 in row 5 | Box 8 in row 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
box 9 in row 6 | box 10 in row 6 | Box 11 in row 6 | Box 12 in row 6 | Box 13 in row 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ G01 }}} | {{{ G03 }}} | {{{ G04 }}} | {{{ G05 }}} | {{{ G06 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
Dont's
References
- ↑ Baddour Larry M., Wilson Walter R., Bayer Arnold S., Fowler Vance G. Jr, Bolger Ann F., Levison Matthew E., Ferrieri Patricia, Gerber Michael A., Tani Lloyd Y., Gewitz Michael H., Tong David C., Steckelberg James M., Baltimore Robert S., Shulman Stanford T., Burns Jane C., Falace Donald A., Newburger Jane W., Pallasch Thomas J., Takahashi Masato, Taubert Kathryn A. (2005). "Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association-Executive Summary: Endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): 3167–84. PMID 15956145.